| Summary: | <i>Staphylococcus aureus</i> (SA) and <i>Streptococcus</i> species (SS) show different clinical manifestations in infective endocarditis (IE), but the impact on the complexity of surgical treatment remains unclear. All patients with surgically treated IE due to SA or SS between July 2013 and December 2016 were extracted from a prospectively collected, single-center registry. Data on patient characteristics, surgical procedures, and postprocedural outcomes were collected. SA-IE was more common with prosthetic valves (26.3% vs. 7.3%, <i>p</i> = 0.04), cardiac devices (14.3% vs. 0%, <i>p</i> = 0.03), previous cardiac surgery (28.6% vs. 9.8%, <i>p</i> = 0.03), intravenous drug abuse (14.3% vs. 0%, <i>p</i> = 0.03), and embolic events (57.1% vs. 26.8%, <i>p</i> = 0.007). Preoperative CRP was significantly higher in SA-IE (median 96.1 mg/L vs. 42.4 mg/L, <i>p</i> = 0.002). Otherwise, SS-IE affected more cusps/leaflets (mean 2.4 vs. 1.8, <i>p</i> = 0.03) and led to more valve dysfunction (83.8% vs. 54.3%, <i>p</i> = 0.007). Surgery times did not differ between the groups, though patients with SA spent more time in the intensive care unit (median 7 vs. 4.5 days, <i>p</i> = 0.04). Hospital mortality did not differ, but patients with SA-IE had unfavorable long-term survival (<i>p</i> = 0.001). Future studies need to be larger and focus on the mechanism behind the reduced long-term survival to mitigate the deleterious effect of SA in surgically treated patients with IE.
|
|---|